Correcting figure in Cantel release; $11,000,000 sted $110,000,000.--(BUSINESS WIRE)-- In BW1208, Cantel Announces Pact With Olympus Upon Approval Of MediVators Merger, in 3rd graph, last line, read it $11,000,000 (sted $110,000,000). The corrected graph follows: James P. Reilly, president and chief executive officer of Cantel Industries Inc., stated, "Having represented Olympus in Canada for the past 50 years, we look forward to this new strategic alliance with Olympus, which will give us the most complete coverage possible of the endoscope endoscope, any instrument used to look inside the body. Usually consisting of a fiber-optic tube attached to a viewing device, endoscopes are used to explore and biopsy such areas as the colon and the bronchi of the lungs. disinfection disinfection, n the process of destroying pathogenic organisms or rendering them inert. disinfection, full oral cavity, n a procedure used to reduce active periodontal disease, usually completed within a certain short time frame. market throughout the Western Hemisphere Western Hemisphere Part of Earth comprising North and South America and the surrounding waters. Longitudes 20° W and 160° E are often considered its boundaries. ." Reilly further stated, "The acquisition of MediVators, a United States company, will also allow us to utilize Cantel's net operating loss operating loss The excess of operating expenses over revenue. As with operating income, operating losses exclude revenues and expenses from operations that are not considered a regular part of the business. Also called deficit. Compare operating income. carryforward of approximately $11,000,000." CONTACT: Cantel Industries Inc. James P. Reilly, 201/470-8700 or Martin E. Janis & Company Inc. Bev Jedynak, 312/943-1100 |
|
||||||||||||||
Printer friendly
Cite/link
Email
Feedback
Reader Opinion